TO WEAR A NOSTRADAMUS HAT: DRUGS AND AMERICABLUM R. H.J. SOC. ISSUES. 1971, Vol 27, Num 3, pp 89-106Article

Hypothesis: a new basis for sensory-behavioral pretreatments to ameliorate radiation therapy-induced nausea and vomiting?BLUM, R. H.Cancer treatment reviews. 1988, Vol 15, Num 3, pp 211-227, issn 0305-7372Article

Psychiatrie sociale aux Etats-Unis: évolution contemporaine = Social psychiatry in the United States: actual evolutionBLUM, R. H; HAYNAL, A.Médecine et hygiène. 1985, Vol 43, Num 1612, pp 1893-1902, issn 0025-6749Article

Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma : the Eastern Cooperative Oncology Group trial EST 1684KIRKWOOD, J. M; STRAWDERMAN, M. H; ERNSTOFF, M. S et al.Journal of clinical oncology. 1996, Vol 14, Num 1, pp 7-17, issn 0732-183XArticle

ICRF-187 permits longer treatment with doxorubicin in women with breast cancerSPEYER, J. L; GREEN, M. D; BLUM, R. H et al.Journal of clinical oncology. 1992, Vol 10, Num 1, pp 117-127, issn 0732-183XArticle

High- and low-dose interferon alfa-2b in high-risk melanoma: First analysis of intergroup trial E1690/S9111/C9190KIRKWOOD, J. M; IBRAHIM, J. G; SONDAK, V. K et al.Journal of clinical oncology. 2000, Vol 18, Num 12, pp 2444-2458, issn 0732-183XArticle

A prospective randomized trial of ICRF-187 for prevention of cumulative doxorubicin-induced cardiac toxicity in women with breast cancerSPEYER, J. L; GREEN, M. D; MUGGIA, F. M et al.Cancer treatment reviews. 1990, Vol 17, Num 2-3, pp 161-163, issn 0305-7372, 3 p.Article

A phase III randomized trial of epirubicin versus 5-fluorouracil in metastatic rectal/sigmoid adenocarcinomaMOLINARO, P; LAFLEUR, F; BLUM, R. H et al.American journal of clinical oncology. 1989, Vol 12, Num 4, pp 332-334, issn 0277-3732Article

Effect of adjuvant central Iv hyperalimentation on the survival and response to treatment of patients with small cell lung cancer: a randomized trialCLAMON, G. H; FELD, R; EVANS, W. K et al.Cancer treatment reports. 1985, Vol 69, Num 2, pp 167-177, issn 0361-5960Article

A randomized phase II trial of echinomycin, trimetrexate, and cisplatin plus etoposide in patients with metastatic nonsmall cell lung carcinoma : An Eastern Cooperative Oncology Group Study (E1587)CHANG, A. Y; KIM, K; BOUCHER, H et al.Cancer. 1998, Vol 82, Num 2, pp 292-300, issn 0008-543XArticle

Efficacy of ifosfamide in combination with doxorubicin for the treatment of metastatic soft-tissue sarcomaBLUM, R. H; EDMONSON, J; RYAN, L et al.Cancer chemotherapy and pharmacology. 1993, Vol 31, pp S238-S240, issn 0344-5704, SUP2Conference Paper

Phase I trial of escalating dose doxorubicin administered concurrently with α₂-interferonGREEN, M. D; SPEYER, J. L; HOCHSTER, H. S et al.Cancer research (Baltimore). 1988, Vol 48, Num 9, pp 2574-2578, issn 0008-5472Article

Phase I trial of low-dose continuous topotecan infusion in patients with cancer : an active and well-tolerated regimenHOCHSTER, H; LIEBES, L; BLUM, R. H et al.Journal of clinical oncology. 1994, Vol 12, Num 3, pp 553-559, issn 0732-183XArticle

Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mitomycin, doxorubicin, and cisplatin against advanced soft tissue sarcomasEDMONSON, J. H; RYAN, L. M; BLUM, R. H et al.Journal of clinical oncology. 1993, Vol 11, Num 7, pp 1269-1275, issn 0732-183XArticle

Phase I study of doxorubicin, ICRF-187 and granulocyte/macrophage-colony-stimulating factorWALSH, C; BLUM, R. H; ORATZ, R et al.Journal of cancer research and clinical oncology. 1992, Vol 118, Num 1, pp 61-66, issn 0171-5216Article

Cisplatin and vinblastine chemotherapy for metastatic non-small cell carcinoma followed by irradiation in patients with regional diseaseBLUM, R. H; COOPER, J; SCHMIDT, A. M et al.Cancer treatment reports. 1986, Vol 70, Num 3, pp 333-337, issn 0361-5960Article

Prospective evaluation of cardiotoxicity during a six-hour doxorubicin infusion regimen in women with adenocarcinoma of the breastSPEYER, J. L; GREEN, M. D; DUBIN, N et al.The American journal of medicine. 1985, Vol 78, Num 4, pp 555-562, issn 0002-9343Article

Phase II trial of cyclophosphamide and cis-platinum for non-small cell bronchogenic carcinomaSCHMIDT, A. M; BLUM, R. H; CLAYTON, M et al.American journal of clinical oncology. 1984, Vol 7, Num 6, pp 725-727, issn 0277-3732Article

Phase Ib of granulocyte-macrophage colony-stimulating factor combined with murine monoclonal antibody R24 in patients with metastatic melanomaCHACHOUA, A; ORATZ, R; LIEBES, L et al.Journal of immunotherapy. 1994, Vol 16, Num 2, pp 132-141, issn 1053-8550Conference Paper

Pharmacokinetics of the cardioprotector ADR-529 (ICRF-187) in escalating doses combined with fixed-dose doxorubicinHOCHSTER, H; LIEBES, L; WADLER, S et al.Journal of the National Cancer Institute. 1992, Vol 84, Num 22, pp 1725-1730, issn 0027-8874Article

A pilot study of three sequential chemotherapeutic regimens in metastatic breast cancerRANSOM, D. T; LOPRINZI, C. L; TORMEY, D. C et al.American journal of clinical oncology. 1991, Vol 14, Num 1, pp 45-48, issn 0277-3732, 4 p.Article

Management of cancer pain with oral controlled-release morphine sulfateMEED, S. D; KLEINMAN, P. M; KANTOR, T. G et al.Journal of clinical pharmacology. 1987, Vol 27, Num 2, pp 155-161, issn 0091-2700Article

Activity of epirubicin in pancreatic carcinomaHOCHSTER, H; GREEN, M. D; SPEYER, J. L et al.Cancer treatment reports. 1986, Vol 70, Num 2, pp 299-300, issn 0361-5960Article

Phase I-II study of the continuous infusion of doxorubicin in the treatment of non-small cell lung cancer = Essai phase I-II de l'adriamycine en perfusion continue dans les tumeurs bronchiques non microcytairesGREEN, M. D; SPEYER, J. S; BOTTINO, J. C et al.Cancer treatment reports. 1984, Vol 68, Num 4, pp 681-682, issn 0361-5960Article

Treatment of massive intrathecal methotrexate overdose by ventriculolumbar perfusion = Traitement d'un surdosage massif de méthotrexate intrathécal par perfusion ventriculorachidienneSPIEGEL, R. J; COOPER, P. R; BLUM, R. H et al.The New England journal of medicine. 1984, Vol 311, Num 6, pp 386-388, issn 0028-4793Article